This cross-sectional pilot study tested 1,812 symptomatic adults in Kazakhstan for COVID-19 and other respiratory viruses during a low transmission period in 2021.
PeerJ · 6 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This cross-sectional pilot study tested 1,812 symptomatic adults in Kazakhstan for COVID-19 and other respiratory viruses during a low transmission period in 2021.
This cross-sectional pilot study characterized viral causes of symptomatic upper respiratory tract infection (RTI) in 1,812 adults presenting at outpatient clinics in Almaty, Kazakhstan during May-June 2021, a period of low COVID-19 transmission. Initial screening found 21/1,812 (1.2%) were SARS-CoV-2 positive. A subset of 50 SARS-CoV-2-negative adults underwent further testing, revealing 33/50 (66%) had a positive PCR for another virus: 25/50 (50%) had human parainfluenza virus (predominantly type 4), 2/50 (4%) had rhinovirus, 4/50 (8%) had a co-infection of hPIV-4 and rhinovirus, and 2/50 (4%) had adenovirus or a coronavirus (HKU-1/OC43). Virome sequencing characterized rhinovirus and hPIV-3 in 6 of 33 PCR-positive samples. Limitations include the small subset size, cross-sectional design preventing seasonality analysis, and the fact that pathogen detection does not prove causation. The findings suggest non-COVID-19 viruses were predominant causes of symptomatic RTI in this population during low SARS-CoV-2 circulation.